<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02990273</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00113092</org_study_id>
    <nct_id>NCT02990273</nct_id>
  </id_info>
  <brief_title>The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures</brief_title>
  <official_title>The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Li, Zhiping, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Li, Zhiping, M.D.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cirrhosis results in decreased synthesis of both procoagulants and anticoagulants resulting
      in &quot;rebalanced homeostasis&quot;. However, conventional blood tests (platelets/ INR levels) that
      are performed prior to invasive procedures do not accurately reflect the coagulation changes
      that occur in cirrhotics, resulting in unnecessary transfusion of blood products.
      Thromboelastography (TEG) is a global hemostasis assessment tool that is being used in
      surgery (including liver transplant) to help guide blood product transfusion in the operating
      room. The investigators would like to compare the use of TEG vs. INR/platelets to help guide
      blood product transfusion in cirrhotic patients undergoing inpatient endoscopy. The
      investigators will evaluate to see if there is a decrease in prophylactic blood transfusions
      prior to endoscopy when using TEG.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Units of fresh frozen plasma and platelet trasnfused</measure>
    <time_frame>2 week</time_frame>
    <description>Will compare how much PPF and platelet transfusion patients receiving between 2 groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Cirrhosis, Coagulopathy</condition>
  <arm_group>
    <arm_group_label>TEG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Blood transfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PT/INR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Blood transfusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood transfusion</intervention_name>
    <arm_group_label>TEG</arm_group_label>
    <arm_group_label>PT/INR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All 18 yo + cirrhotic patients who are being scheduled for inpatient endoscopy

        Exclusion Criteria:

          -  Patients on blood thinners (prophylactic anticoagulation is permissible)

          -  Hemodynamically unstable patients requiring pressors (ie ICU level patients)

          -  Pregnant or lactating individuals

          -  Inability to provide consent for any reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2016</study_first_submitted>
  <study_first_submitted_qc>December 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2016</study_first_posted>
  <last_update_submitted>December 8, 2016</last_update_submitted>
  <last_update_submitted_qc>December 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Zhiping Li, MD</investigator_full_name>
    <investigator_title>Director of Hepatology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

